These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 32831131)
1. Gene co-expression and histone modification signatures are associated with melanoma progression, epithelial-to-mesenchymal transition, and metastasis. Azevedo H; Pessoa GC; de Luna Vitorino FN; Nsengimana J; Newton-Bishop J; Reis EM; da Cunha JPC; Jasiulionis MG Clin Epigenetics; 2020 Aug; 12(1):127. PubMed ID: 32831131 [TBL] [Abstract][Full Text] [Related]
2. Transcriptional signatures underlying dynamic phenotypic switching and novel disease biomarkers in a linear cellular model of melanoma progression. Pessoa DO; Rius FE; Papaiz DD; Ayub ALP; Morais AS; de Souza CF; da Paixão VF; Setubal JC; Newton-Bishop J; Nsengimana J; Azevedo H; Reis EM; Jasiulionis MG Neoplasia; 2021 Apr; 23(4):439-455. PubMed ID: 33845354 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic reprogramming as a key contributor to melanocyte malignant transformation. Molognoni F; Cruz AT; Meliso FM; Morais AS; Souza CF; Xander P; Bischof JM; Costa FF; Soares MB; Liang G; Jones PA; Jasiulionis MG Epigenetics; 2011 Apr; 6(4):450-64. PubMed ID: 21343701 [TBL] [Abstract][Full Text] [Related]
4. Mining gene expression signature for the detection of pre-malignant melanocytes and early melanomas with risk for metastasis. de Souza CF; Xander P; Monteiro AC; Silva AG; da Silva DC; Mai S; Bernardo V; Lopes JD; Jasiulionis MG PLoS One; 2012; 7(9):e44800. PubMed ID: 22984562 [TBL] [Abstract][Full Text] [Related]
5. Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation. Toricelli M; Melo FH; Peres GB; Silva DC; Jasiulionis MG Mol Cancer; 2013 Mar; 12():22. PubMed ID: 23522389 [TBL] [Abstract][Full Text] [Related]
6. Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells. Ke XS; Qu Y; Cheng Y; Li WC; Rotter V; Øyan AM; Kalland KH BMC Genomics; 2010 Nov; 11():669. PubMed ID: 21108828 [TBL] [Abstract][Full Text] [Related]
7. Genome-wide promoter methylation profiling in a cellular model of melanoma progression reveals markers of malignancy and metastasis that predict melanoma survival. Rius FE; Papaiz DD; Azevedo HFZ; Ayub ALP; Pessoa DO; Oliveira TF; Loureiro APM; Andrade F; Fujita A; Reis EM; Mason CE; Jasiulionis MG Clin Epigenetics; 2022 May; 14(1):68. PubMed ID: 35606887 [TBL] [Abstract][Full Text] [Related]
8. The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion. Fenouille N; Tichet M; Dufies M; Pottier A; Mogha A; Soo JK; Rocchi S; Mallavialle A; Galibert MD; Khammari A; Lacour JP; Ballotti R; Deckert M; Tartare-Deckert S PLoS One; 2012; 7(7):e40378. PubMed ID: 22911700 [TBL] [Abstract][Full Text] [Related]
9. Cellular Model of Colon Cancer Progression Reveals Signatures of mRNAs, miRNA, lncRNAs, and Epigenetic Modifications Associated with Metastasis. Rokavec M; Horst D; Hermeking H Cancer Res; 2017 Apr; 77(8):1854-1867. PubMed ID: 28130225 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma. Gong F; Guo Y; Niu Y; Jin J; Zhang X; Shi X; Zhang L; Li R; Chen L; Ma RZ Oncotarget; 2017 Jan; 8(1):315-328. PubMed ID: 27852070 [TBL] [Abstract][Full Text] [Related]
11. Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. Ronca R; Di Salle E; Giacomini A; Leali D; Alessi P; Coltrini D; Ravelli C; Matarazzo S; Ribatti D; Vermi W; Presta M Mol Cancer Ther; 2013 Dec; 12(12):2760-71. PubMed ID: 24130051 [TBL] [Abstract][Full Text] [Related]
12. Hypoxia promotes the metastasis of pancreatic cancer through regulating NOX4/KDM5A-mediated histone methylation modification changes in a HIF1A-independent manner. Li H; Peng C; Zhu C; Nie S; Qian X; Shi Z; Shi M; Liang Y; Ding X; Zhang S; Zhang B; Li X; Xu G; Lv Y; Wang L; Friess H; Kong B; Zou X; Shen S Clin Epigenetics; 2021 Jan; 13(1):18. PubMed ID: 33499904 [TBL] [Abstract][Full Text] [Related]
13. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition. Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic control of epithelial-to-mesenchymal transition and cancer metastasis. Wang Y; Shang Y Exp Cell Res; 2013 Jan; 319(2):160-9. PubMed ID: 22935683 [TBL] [Abstract][Full Text] [Related]
16. Whole transcriptome analysis reveals correlation of long noncoding RNA ZEB1-AS1 with invasive profile in melanoma. Siena ÁDD; Plaça JR; Araújo LF; de Barros II; Peronni K; Molfetta G; de Biagi CAO; Espreafico EM; Sousa JF; Silva WA Sci Rep; 2019 Aug; 9(1):11350. PubMed ID: 31383874 [TBL] [Abstract][Full Text] [Related]
17. The Role of PPARβ/δ in Melanoma Metastasis. Lim JCW; Kwan YP; Tan MS; Teo MHY; Chiba S; Wahli W; Wang X Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30241392 [TBL] [Abstract][Full Text] [Related]
18. p32 promotes melanoma progression and metastasis by targeting EMT markers, Akt/PKB pathway, and tumor microenvironment. Sinha S; Singh SK; Jangde N; Ray R; Rai V Cell Death Dis; 2021 Oct; 12(11):1012. PubMed ID: 34711805 [TBL] [Abstract][Full Text] [Related]
19. G9a and histone deacetylases are crucial for Snail2-mediated E-cadherin repression and metastasis in hepatocellular carcinoma. Hu Y; Zheng Y; Dai M; Wang X; Wu J; Yu B; Zhang H; Cui Y; Kong W; Wu H; Yu X Cancer Sci; 2019 Nov; 110(11):3442-3452. PubMed ID: 31432592 [TBL] [Abstract][Full Text] [Related]
20. The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer. Ezponda T; Popovic R; Shah MY; Martinez-Garcia E; Zheng Y; Min DJ; Will C; Neri A; Kelleher NL; Yu J; Licht JD Oncogene; 2013 Jun; 32(23):2882-90. PubMed ID: 22797064 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]